Silver Book Fact

The projected economic value of eliminating deaths from heart disease is approximately $48 trillion.

Murphy, Kevin M. and Robert H. Topel. Measuring the Gains from Medical Research: An economic approach. Chicago, IL: The University of Chicago Press; 2003

Reference

Title
Measuring the Gains from Medical Research: An economic approach
Publisher
The University of Chicago Press
Publication Date
2003
Authors
Murphy, Kevin M. and Robert H. Topel

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • In 1995, an NIH-funded clinical trial established the first FDA-approved treatment for acute ischemic stroke treatment.The drug tPA, if given within 3 hours of stroke symptoms, reduces the risk of…  
  • 5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.  
  • Survival rates of SAS patients ages 80+ with and without SAVR
     
  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.  
  • Every additional dollar spent on antiplatelet therapy versus aspirin for the prevention of stroke in high-risk patients, has produced health gains valued between $2 and $6.